Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
- Conditions
- Pediatric Cancer
- Interventions
- Other: Patient population
- Registration Number
- NCT05305950
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
This study aims to identify the modifiable facilitators and barriers to occupational and physical therapy care for children during and after cancer treatment that may be contributing to disparities in health outcomes. The investigators will identify these facilitators and barriers by surveying and interviewing healthcare administrators at MD Anderson Cancer center. The investigators will also survey and interview physicians, advanced practice providers, and occupational and physical therapists to obtain their feedback on these issues.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Employed as an administrator at MD Anderson Cancer Center and the sister institutions and working in the areas of pediatrics, survivorship, cancer control, health policy, and rehabilitation services.
Aim 2 Inclusion Criteria:
- Employed as a referring provider (e.g., oncologist, surgeon, advanced care practitioner), or an OT/PT therapist at MD Anderson Cancer Center and the sister institutions.
- Inability to provide informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Physicians/referring providers Patient population Physicians/referring providers and the occupational therapy (OT) and physical therapy (PT) therapists at MD Anderson Cancer Center and the sister institutions Healthcare administrators Patient population Healthcare administrators at MD Anderson Cancer Center and the sister institutions
- Primary Outcome Measures
Name Time Method Identify modifiable barriers to occupational and physical therapy care for children during cancer treatment that may be contributing to disparities in health outcomes. Through study completion, an average of 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
M D Anderson Cancer Center
🇺🇸Houston, Texas, United States